Doctors over Prescribing
Researchers at Dartmouth Medical School estimate tens of millions more Americans were diagnosed with a sickness or health problem during the 1990s than before. One reason points to the fact that definitions of diseases have changed. And behind those changes, are USA pharma companies wanting to classify more healthy people as sick—and doctors over prescribing medications to their patients.Dartmouth further illustrates that every time the boundary of a disease is expanded, e.g., when the hypertension threshold is lowered by 10 blood-pressure points or the guideline for obesity is lowered by 5 pounds, the market for drugs is expanded by millions of consumers and billions of dollars.
The change in criteria and definitions of what is considered sick also encourages physicians’ overprescribing. Due to doctors over prescribing millions of people are taking drugs that they don’t really need and may carry a greater risk than the underlying condition. And the treatment or over prescribing may make them sick or even kill them. Don’t be fooled. Learn your rights based on suffering from overprescribing by your physician.
Problems with the Expanding Definitions of Diseases
The Seattle Times reported that USA pharma companies influence doctors’ diagnoses in an effort to improve their bottom lines. The report uncovered the fact that USA pharma companies give money to members of the World Health Organization, U.S. National Institute of Health and some of America’s most prestigious medical societies for these institutions to promote the pharmaceutical manufacturers industry’s agenda.
As a result, today three in four Americans are considered to have at least one disease, but millions of these people are truly not sick, resulting in sales of drugs and over prescribing of drugs, to people who do not need them, but can afford to pay for them.
The Times also found that for a broad spectrum of diseases, the experts writing the treatment guidelines had USA pharma companies ties ranging from research contracts to consultancies to stock ownership. A recent example includes the satin drugs. With a change in the guidelines of what it means to have high blood pressure, it increased the market for statin drugs, which are used to lower cholesterol in adults. It was learned that six of the nine experts on cholesterol who contributed to the new guidelines had financial ties to the USA pharma companies who produce the most commonly used statin drugs.
Our Practices
- Asbestos
- Class Actions
- Commercial Litigation
- Defective Products
- Drug Injury
- Personal Injury
- Securities Fraud
- Toxic Exposure
Current Investigations
- Accutane Side Effects
- Darvon and Darvocet
- DePuy Hip Recall
- Fosamax Femur Fractures
- Muscle Injury
- Sleeping Pill Dangers
- SSRI Birth Defects
- Topamax Birth Defects
- Transvaginal Surgical Mesh and Bladder Slings
- Tylenol Liver Damage
- Zocor/Simvastatin
Pending Settlements







